41448 Federal Register / Vol. 74, No. 157 / Monday, August 17, 2009 / Notices 

Agenda: To review and evaluate grant 

applications and/or proposals 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817 

Open: 10:00 a.m. to 5:00 p.m. 

Agenda: The agenda will include opening 

remarks, administrative matters, Director’s 

Report, NCMHD Health Disparities update, 

Scientific Programs Highlight, and other 

business of the Council. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817 

Contact Person: Donna Brooks, Asst. 

Director for Administration, National Center 

on Minority Health and Health Disparities, 

National Institutes of Health, 6707 

Democracy Blvd., Suite 800, Bethesda, MD 

20892, 301–435–2135, brooksd@

ncmhd.nih.gov. 

This meeting is being published less than 

15 days prior to the meeting due to the 

timing limitations imposed by the review and 

funding cycle. 

Any member of the public interested in 

presenting oral comments to the committee 

may notify the Contact Person listed on this 

notice at least 10 days in advance of the 

meeting. Interested individuals and 

representatives of organizations may submit 

a letter of intent, a brief description of the 

organization represented, and a short 

description of the oral presentation. Only one 

representative of an organization may be 

allowed to present oral comments and if 

accepted by the committee, presentations 

may be limited to five minutes. Both printed 

and electronic copies are requested for the 

record. In addition, any interested person 

may file written comments with the 

committee by forwarding their statement to 

the Contact Person listed on this notice. The 

statement should include the name, address, 

telephone number and when applicable, the 

business or professional affiliation of the 

interested person. 

Dated: August 11, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–19690 Filed 8–14–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Research 

Resources; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

ARRA STRB September Meeting 1. 

Date: September 8–11, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892. (Virtual 

Meeting). 

Contact Person: Mohan Viswanathan, PhD, 

Scientific Review Officer, National Center for 

Research Resources, National Institutes of 

Health, One Democracy Plaza, 6701 

Democracy Blvd., Room 1084, Bethesda, MD 

20892–4874. 301–435–0829. mv10f@nih.gov. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

ARRA STRB September Meeting 2. 

Date: September 8–11, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892 (Virtual 

Meeting). 

Contact Person: Mohan Viswanathan, PhD, 

Scientific Review Officer, National Center for 

Research Resources, National Institutes of 

Health, One Democracy Plaza, 6701 

Democracy Blvd., Room 1084, Bethesda, MD 

20892–4874. 301–435–0829. Mv10f@nih.gov. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

ARRA STRB September Meeting 3. 

Date: September 8–11, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892 (Virtual 

Meeting). 

Contact Person: Carol Lambert, PhD, 

Scientific Review Officer, Office of Review, 

National Institutes of Health, NCRR, 6701 

Democracy Blvd., 1 Democracy Plaza, Room 

1076, MSC 4874, Bethesda, MD 20892. (301) 

435–0814. lambert@mail.nih.gov. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

ARRA STRB September Meeting 4. 

Date: September 8–11, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892 (Virtual 

Meeting). 

Contact Person: Carol Lambert, PhD, 

Scientific Review Officer, Office of Review, 

National Institutes of Health, NCRR, 6701 

Democracy Blvd., 1 Democracy Plaza, Room 

1076, MSC 4874, Bethesda, MD 20892. (301) 

435–0814. lambert@mail.nih.gov. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

Comparative Medicine SEP. 

Date: September 22, 2009. 

Time: 12 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Lisa A Newman, SCD, 

Scientific Review Officer, National Institutes 

of Health, National Center for Research 

Resources, Office of Review, Room 1074, 

6701 Democracry Blvd. MSC 4874, Bethesda, 

MD 20892. 301–435–0965. 

newmanla2@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research; 93.371, Biomedical 

Technology; 93.389, Research Infrastructure, 

93.306, 93.333; 93.702, ARRA Related 

Construction Awards., National Institutes of 

Health, HHS) 

Dated: August 11, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–19689 Filed 8–14–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; ‘‘Bacterial Immunity’’. 

Date: September 8, 2009. 

Time: 12:30 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge 6700, 6700B Rockledge Drive, 

Bethesda, MD 20817 (Telephone Conference 

Call) 

Contact Person: Annie Walker-Abbey, PhD, 

Scientific Review Officer, Scientific Review 

Program, NIAID/NIH/DHHS, 6700B 

Rockledge Drive, RM 3266, MSC–7616, 

Bethesda, MD 20892–7616, 301–451–2671, 

aabbey@niaid.nih.gov. 

mstockstill on DSKH9S0YB1PROD with NOTICES

Federal Register / Vol. 74, No. 157 / Monday, August 17, 2009 / Notices 41449 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Immune Protection to 

Highly Lethal Pathogens by CD45 

Modulation. 

Date: September 9, 2009. 

Time: 12 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge 6700, 6700B Rockledge Drive, 

Bethesda, MD 20817 (Telephone Conference 

Call). 

Contact Person: Raymond Richard Schleef, 

PhD, Scientific Review Officer, Scientific 

Review Program, Division of Extramural 

Activities, National Institutes of Health/ 

NIAID, 6700B Rockledge Drive, MSC 7616, 

Bethesda, MD 20892–7616, 301–451–3679, 

schleefrr@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: August 11, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–19687 Filed 8–14–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Dental & 

Craniofacial Research; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

National Advisory Dental and 

Craniofacial Research Council. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Dental and Craniofacial Research Council. 

Date: August 31, 2009. 

Time: 12 p.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Bethesda, MD 

20892 (Telephone Conference Call). 

Contact Person: Alicia J. Dombroski, PhD, 

Director, Division of Extramural Activities, 

Natl Inst of Dental and Craniofacial Research, 

National Institutes of Health, Bethesda, MD 

20892. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www.nidcr.nih.gov/about, where an agenda 

and any additional information for the 

meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.121, Oral Diseases and 

Disorders Research, National Institutes of 

Health, HHS) 

Dated: August 11, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–19686 Filed 8–14–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0664] 

Vaccines and Related Biological 

Products Advisory Committee; Notice 

of Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

This notice announces a forthcoming 

meeting of a public advisory committee 

of the Food and Drug Administration 

(FDA). The meeting will be open to the 

public. 

Name of Committee: Vaccines and 

Related Biological Products Advisory 

Committee. 

General Function of the Committee: 

To provide advice and 

recommendations to the agency on 

FDA’s regulatory issues. 

Date and Time: The meeting will be 

held on September 9, 2009, from 8 a.m. 

to approximately 5 p.m. 

Location: Hilton Hotel, Washington 

DC North/Gaithersburg, 620 Perry 

Pkwy., Gaithersburg, MD 20877. 

Contact Person: Christine Walsh or 

Denise Royster, Center for Biologics 

Evaluation and Research (HFM–71), 

Food and Drug Administration, 1401 

Rockville Pike, Rockville, MD 20852, 

301–827–0314, or FDA Advisory 

Committee Information Line, 1–800– 

741–8138 (301–443–0572 in the 

Washington, DC area), code 

3014512391. Please call the Information 

Line for up-to-date information on this 

meeting. A notice in the Federal 

Register about last minute modifications 

that impact a previously announced 

advisory committee meeting cannot 

always be published quickly enough to 

provide timely notice. Therefore, you 

should always check the agency’s Web 

site and call the appropriate advisory 

committee hot line/phone line to learn 

about possible modifications before 

coming to the meeting. 

Agenda: On September 9, 2009, in the 

morning, the committee will discuss 

and make recommendations on the 

safety and effectiveness in females of a 

vaccine manufactured by 

GlaxoSmithKline against Human 

Papillomavirus. In the afternoon, the 

committee will discuss and make 

recommendations on the safety and 

effectiveness of vaccinating males with 

Gardasil, a vaccine manufactured by 

Merck & Co. against Human 

Papillomavirus. 

FDA intends to make background 

material available to the public no later 

than 2 business days before the meeting. 

If FDA is unable to post the background 

material on its Web site prior to the 

meeting, the background material will 

be made publicly available at the 

location of the advisory committee 

meeting, and the background material 

will be posted on FDA’s Web site after 

the meeting. Background material is 

available at http://www.fda.gov/ 

AdvisoryCommittees/Calendar/ 

default.htm. Scroll down to the 

appropriate advisory committee link. 

Procedure: Interested persons may 

present data, information, or views, 

orally or in writing, on issues pending 

before the committee. Written 

submissions may be made to the contact 

person on or before September 4, 2009. 

Oral presentations from the public will 

be scheduled between approximately 

11:30 a.m. and 12 noon and between 

approximately 3:40 p.m. and 4:10 p.m. 

Those desiring to make formal oral 

presentations should notify the contact 

person and submit a brief statement of 

the general nature of the evidence or 

arguments they wish to present, the 

names and addresses of proposed 

participants, and an indication of the 

approximate time requested to make 

their presentation on or before August 

27, 2009. Time allotted for each 

presentation may be limited. If the 

number of registrants requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

open public hearing session, FDA may 

conduct a lottery to determine the 

speakers for the scheduled open public 

hearing session. The contact person will 

notify interested persons regarding their 

request to speak by September 3, 2009. 

Persons attending FDA’s advisory 

committee meetings are advised that the 

mstockstill on DSKH9S0YB1PROD with NOTICES